NRBO - NeuroBo Pharmaceuticals regains compliance with Nasdaq minimum bid price requirement
- NeuroBo Pharmaceuticals ( NASDAQ: NRBO ) received Nasdaq notification indicating that the company has evidenced full compliance with the minimum bid price requirement
- As a result, the listing matter has been closed.
- Shares are trading up 4% premarket.
For further details see:
NeuroBo Pharmaceuticals regains compliance with Nasdaq minimum bid price requirement